Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO

Latest clinical data and research illustrate Regeneron’s advancement of innovative science for diverse and serious diseases with significant unmet needsTARRYTOWN, N.Y., June 04, 2026 (GLOBE NEWSWIRE) ...
Biz New Orleans

Ochsner Highlights 450 Active Clinical Trials

Ochsner Health celebrated its 23rd annual Research Week from May 18 through May 21, highlighting biomedical research and ...
STAT

My oral cancer shows the deep connections between chronic and infectious disease

Schlesinger is a physician-scientist and professor, president, and CEO of Texas Biomedical Research Institute, a nonprofit research organization in San Antonio, Texas. The connection between infection ...
CNBC

Rare disease families find roadmap to drug development at bootcamps

Rare disease families are increasingly driving research efforts to find treatments for their children. Ultragenyx’s Rare Bootcamp gives advocates a roadmap for navigating drug development. The program ...
CBS News

Lyme disease research at Johns Hopkins in jeopardy due to federal funding delays

Maryland has some of the highest cases of Lyme disease in the nation, yet funding for research is in jeopardy. Lyme disease is the most common and fastest-growing vector-borne disease in the United ...
Healio

ASH sickle cell disease research priorities address pain, organ dysfunction, drug development

Please provide your email address to receive an email when new articles are posted on . ASH issued sickle cell disease research priorities that address seven key focus areas. Topics include end-organ ...